Literature DB >> 25225192

Chloroquine cardiomyopathy: beyond ocular adverse effects.

Nilson Lopez-Ruiz1, Carlos Esteban Uribe2.   

Abstract

A 36-year-old woman who had received long-term treatment with chloroquine for systemic lupus erythematosus developed a third degree atrioventricular block and required a permanent pacemaker. Notably, left ventricular thickening and mild systolic dysfunction were noticed on echocardiography as well as on cardiac MRI. As there was no clear explanation for myocardial findings, the patient underwent an endomyocardial biopsy that demonstrated vacuolar degeneration of myocytes on light microscopy and curvilinear bodies on electron microscopy, both findings consistent with chloroquine toxicity. The drug was withheld and treatment with candesartan and carvedilol was prescribed. At 2-year follow-up, the patient remained asymptomatic and left ventricular systolic function had improved. Physicians who prescribe antimalarial drugs for rheumatic diseases should be aware of the potentially life-threatening effects of chloroquine on the heart. 2014 BMJ Publishing Group Ltd.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25225192      PMCID: PMC4166238          DOI: 10.1136/bcr-2014-205751

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  18 in total

1.  Fabry's disease cardiomyopathy: echocardiographic detection of endomyocardial glycosphingolipid compartmentalization.

Authors:  Maurizio Pieroni; Cristina Chimenti; Francesco De Cobelli; Emanuela Morgante; Alessandro Del Maschio; Carlo Gaudio; Matteo Antonio Russo; Andrea Frustaci
Journal:  J Am Coll Cardiol       Date:  2006-03-29       Impact factor: 24.094

2.  Recommendations on screening for chloroquine and hydroxychloroquine retinopathy: a report by the American Academy of Ophthalmology.

Authors:  Michael F Marmor; Ronald E Carr; Michael Easterbrook; Ayad A Farjo; William F Mieler
Journal:  Ophthalmology       Date:  2002-07       Impact factor: 12.079

3.  Images in cardiovascular medicine. Contrast-enhanced magnetic resonance imaging of a patient with chloroquine-induced cardiomyopathy confirmed by endomyocardial biopsy.

Authors:  Thorsten Reffelmann; Amjad Naami; Elmar Spuentrup; Harald Peter Kühl
Journal:  Circulation       Date:  2006-08-22       Impact factor: 29.690

4.  Long-term effectiveness of antimalarial drugs in rheumatic diseases.

Authors:  J A Aviña-Zubieta; G Galindo-Rodriguez; S Newman; M E Suarez-Almazor; A S Russell
Journal:  Ann Rheum Dis       Date:  1998-10       Impact factor: 19.103

Review 5.  Chloroquine cardiomyopathy - a review of the literature.

Authors:  Ernst Tönnesmann; Reinhard Kandolf; Thorsten Lewalter
Journal:  Immunopharmacol Immunotoxicol       Date:  2013-05-01       Impact factor: 2.730

Review 6.  Histological and ultrastructural findings in chloroquine-induced cardiomyopathy.

Authors:  C August; H J Holzhausen; A Schmoldt; R Pompecki; S Schröder
Journal:  J Mol Med (Berl)       Date:  1995-02       Impact factor: 4.599

Review 7.  A meta-analysis of the efficacy and toxicity of combining disease-modifying anti-rheumatic drugs in rheumatoid arthritis based on patient withdrawal.

Authors:  E H S Choy; C Smith; C J Doré; D L Scott
Journal:  Rheumatology (Oxford)       Date:  2005-07-19       Impact factor: 7.580

Review 8.  Cardiac damage from chronic use of chloroquine: a case report and review of the literature.

Authors:  Ricardo Alkmim Teixeira; Martino Martinelli Filho; Luiz Alberto Benvenuti; Roberto Costa; Anísio A Pedrosa; Silvana A D Nishióka
Journal:  Arq Bras Cardiol       Date:  2002-07       Impact factor: 2.000

9.  Myocardial left ventricular dysfunction in patients with systemic lupus erythematosus: new insights from tissue Doppler and strain imaging.

Authors:  Sebastian J Buss; David Wolf; Grigorios Korosoglou; Regina Max; Celine S Weiss; Christian Fischer; Dieter Schellberg; Christian Zugck; Helmut F Kuecherer; Hanns-Martin Lorenz; Hugo A Katus; Stefan E Hardt; Alexander Hansen
Journal:  J Rheumatol       Date:  2009-12-01       Impact factor: 4.666

10.  Chloroquine cardiotoxicity: clinicopathologic features in three patients and comparison with three patients with Fabry disease.

Authors:  James M Roos; Marie-Christine Aubry; William D Edwards
Journal:  Cardiovasc Pathol       Date:  2002 Sep-Oct       Impact factor: 2.185

View more
  3 in total

1.  Cardiac Complications Attributed to Chloroquine and Hydroxychloroquine: A Systematic Review of the Literature.

Authors:  Clotilde Chatre; François Roubille; Hélène Vernhet; Christian Jorgensen; Yves-Marie Pers
Journal:  Drug Saf       Date:  2018-10       Impact factor: 5.606

2.  Curvilinear bodies are associated with adverse effects on muscle function but not with hydroxychloroquine dosing.

Authors:  Thomas Khoo; Sophia Otto; Caroline Smith; Barbara Koszyca; Sue Lester; Peter Blumbergs; Vidya Limaye
Journal:  Clin Rheumatol       Date:  2016-09-14       Impact factor: 2.980

3.  Evaluation of Crimean-Congo hemorrhagic fever virus in vitro inhibition by chloroquine and chlorpromazine, two FDA approved molecules.

Authors:  O Ferraris; M Moroso; O Pernet; S Emonet; A Ferrier Rembert; G Paranhos-Baccalà; C N Peyrefitte
Journal:  Antiviral Res       Date:  2015-03-20       Impact factor: 5.970

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.